Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/05/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
57 | |
| 04/05/19 | 8-K | Current report filing |
|
47 | |
| 04/03/19 | 8-K | Current report filing |
|
6 | |
| 04/02/19 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 04/01/19 | 8-K | Current report filing |
|
7 | |
| 03/20/19 | 8-K | Current report filing |
|
52 | |
| 02/25/19 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
6 | |
| 02/22/19 | 8-K | Current report filing |
|
3 | |
| 02/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/14/19 | EFFECT | Notice of Effectiveness |
|
1 |
